Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhichao He

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Expert Opinion on Drug Safety|August 5, 2022
Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance studyJunyan Wu, Jianxiang Huang, Jianhong Zhu, et al.
Eclinicalmedicine|August 13, 2021
Stevens-Johnson syndrome/toxic epidermal necrolysis in patients treated with immune checkpoint inhibitors: A safety analysis of clinical trials and FDA pharmacovigilance databaseJianhong Zhu, Guanghui Chen, Zhichao He, et al.
Food Chemistry|January 24, 2026
Gas-regulating composite films with PBAT microsphere channels and ethylene adsorption for enhanced preservation of perishable fruitsGuang Nie, Wenxuan Zhang, Hao Ding, et al.
Biomaterials Science|April 3, 2023
Injectable chondroitin sulfate-grafted self-antioxidant hydrogels ameliorate nucleus pulposus degeneration against overactive inflammationHuitong Luo, Zetao Wang, Zhichao He, et al.
Scientific Data|June 4, 2024
Gap-free chromosome-level genomes of male and female spotted longbarbel catfish Hemibagrus guttatusYexin Yang, Yi Liu, Fangcan Chen, et al.
Expert Opinion on Drug Safety|January 21, 2020
Risk of adverse events in lymphoma patients treated with brentuximab vedotin: a systematic review and meta-analysisSiyuan Gao, Mei Zhang, Kaishan Wu, et al.
Pharmacoepidemiology and Drug Safety|June 10, 2022
Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System databaseSiyuan Gao, Zhichao He, Jianhong Zhu, et al.
International Immunopharmacology|August 18, 2022
Type 1 diabetes with immune checkpoint inhibitors: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing dataJianhong Zhu, Muhua Luo, Dan Liang, et al.
Stem Cells International|June 15, 2026
Sodium Nitrate Combined With Dental Pulp Stem Cells Alleviates Atherosclerosis Through Inhibiting Oxidative StressZhuang Mao, Han Duan, Zhichao He, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2023
Interstitial lung disease in patients treated with poly (ADP-ribose) polymerase inhibitors (PARPi): analysis of results from clinical trials and the FDA Adverse Events Reporting System databaseZhichao He, Jiayao Mo, Wei Jiang, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Expert Opinion on Drug Safety|August 5, 2022
Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance studyJunyan Wu, Jianxiang Huang, Jianhong Zhu, et al.
Eclinicalmedicine|August 13, 2021
Stevens-Johnson syndrome/toxic epidermal necrolysis in patients treated with immune checkpoint inhibitors: A safety analysis of clinical trials and FDA pharmacovigilance databaseJianhong Zhu, Guanghui Chen, Zhichao He, et al.
Food Chemistry|January 24, 2026
Gas-regulating composite films with PBAT microsphere channels and ethylene adsorption for enhanced preservation of perishable fruitsGuang Nie, Wenxuan Zhang, Hao Ding, et al.
Biomaterials Science|April 3, 2023
Injectable chondroitin sulfate-grafted self-antioxidant hydrogels ameliorate nucleus pulposus degeneration against overactive inflammationHuitong Luo, Zetao Wang, Zhichao He, et al.
Scientific Data|June 4, 2024
Gap-free chromosome-level genomes of male and female spotted longbarbel catfish Hemibagrus guttatusYexin Yang, Yi Liu, Fangcan Chen, et al.
Expert Opinion on Drug Safety|January 21, 2020
Risk of adverse events in lymphoma patients treated with brentuximab vedotin: a systematic review and meta-analysisSiyuan Gao, Mei Zhang, Kaishan Wu, et al.
Pharmacoepidemiology and Drug Safety|June 10, 2022
Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System databaseSiyuan Gao, Zhichao He, Jianhong Zhu, et al.
International Immunopharmacology|August 18, 2022
Type 1 diabetes with immune checkpoint inhibitors: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing dataJianhong Zhu, Muhua Luo, Dan Liang, et al.
Stem Cells International|June 15, 2026
Sodium Nitrate Combined With Dental Pulp Stem Cells Alleviates Atherosclerosis Through Inhibiting Oxidative StressZhuang Mao, Han Duan, Zhichao He, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2023
Interstitial lung disease in patients treated with poly (ADP-ribose) polymerase inhibitors (PARPi): analysis of results from clinical trials and the FDA Adverse Events Reporting System databaseZhichao He, Jiayao Mo, Wei Jiang, et al.
Pageof 6